CAMP and malignant colon neoplasm: Our study demonstrates large-scale metabolic profiling of colon cancer cells after treatment with an antimicrobial peptide, FF/CAP18, and suggests that the apoptotic cell death of colon cancer cells induced by FF/CAP18 is a result of dynamic levels of metabolites.